Recent studies have shown the usefulness of PCR-based restriction fragment length polymorphism (RFLP) analysis for differentiating Helicobacter pylori strains isolated by culture. For this study, a PCR-based RFLP assay was developed for directly typing H. pylori strains from gastric biopsy specimens. Nineteen gastric biopsy specimens obtained from patients undergoing endoscopy for gastrointestinal complaints were cultured for isolation of H. pylori. Genomic DNA preparations from these gastric biopsy specimens and the corresponding H. pylori isolates were tested by our PCR-based RFLP assay. The 1,179-bp H. pylori DNA fragments amplified by the PCR assay were digested with the restriction enzymes HhaI, MboI, and AluI and analyzed by agarose gel electrophoresis. HhaI, MboI, and AluI digestion produced 11, 10, and 6 distinguishable digestion patterns, respectively, from the 19 H. pylori isolates tested and generated 13, 11, and 6 different patterns, respectively, from the 19 gastric biopsy specimens. The patterns from 13 of the 19 gastric biopsy specimens matched those of the H. pylori isolates from the corresponding patients. The patterns from the remaining six biopsy specimens appeared to represent infection by two strains of H. pylori; the pattern of one strain was identical to that of the isolate from the corresponding patient. By combining all the restriction enzyme digestion patterns obtained by using HhaI, MboI, and AluI, we observed 19 distinct RFLP patterns from the 19 specimens. The results suggest that the PCR-based RFLP analysis method may be useful as a primary technique to identify and distinguish H. pylori strains directly from gastric biopsy specimens without culture of the organisms.
Helicobacter pylori is a well-recognized pathogen that causes active chronic gastritis in humans and plays a significant pathogenic role in the development and recurrence of gastric and duodenal ulcers (14) . H. pylori infection may also be associated with gastric cancer (10) and primary gastric B-cell lymphoma (13) . Epidemiologic studies have shown that H. pylori infection occurs worldwide, with a high prevalence rate. Recurrence of infection after apparent eradication has also been reported and is associated with the recurrence of ulcers. However, it is unclear whether the recurrence of ulcers following H. pylori eradication therapy is due to recrudescence of the previous infction or to exogenous reinfection by another strain. An accurate method for the detection and differentiation of H. pylori strains in patients, both before and after therapy, is therefore of great importance for diagnosis, monitoring of treatment, and reduction of the long-term consequences of continued but undetected disease.
Attempts to differentiate H. pylori isolates have been made by using a variety of conventional typing schemes, including hemagglutination (15) ; determination of enzymatic activity (24) , cytotoxin activity (9) , and plasmid profiles (29, 32) ; sodium dodecyl sulfate-polyacrylamide gel electrophoresis of proteins (24) ; and immunoblotting (4) . However, each of these schemes has been of little use for the precise differentiation of H. pylori strains. Although several nucleic acid techniques, such as the restriction endonuclease analysis of genomic DNA (6, 18, 23, 32) and Southern blot hybridization with rRNA gene probes (27) , have been applied to type H. pylori clinical isolates from different patients, the patterns produced by these methods are complex and difficult to interpret, particularly for largescale analyses of clinical isolates. Recently, a PCR-based restriction fragment length polymorphism (RFLP) analysis method has been developed for typing of H. pylori clinical isolates (1, 5, 7, 11, 12, 25) . Schemes involving this method have been used to analyze H. pylori genes which encode urease and its accessory proteins, including the 2.4-kb ureA-ureB (1, 10), 1.7-kb ureC-ureD (1), 933-bp ureB (5), 1.1-kb ureC (25) , and 820-bp ureC (12) genes. Randomly amplified polymorphic DNA has also been used to differentiate H. pylori strains (2) . These data showed that PCR-based RFLP typing was a rapid and sensitive method, but these studies were limited to H. pylori isolates cultured from gastric biopsy specimens.
Here, we report for the first time a PCR-based RFLP analysis method developed to differentiate H. pylori strains directly from gastric biopsy specimens without culture of the organisms. To validate this approach, we compared the RFLP patterns of cultured H. pylori isolates with those of their corresponding gastric-biopsy specimens derived from 19 patients. The restriction enzymes HhaI, MboI, and AluI generated 13, 11, and 6 different patterns, respectively, from the 19 gastric biopsy specimens. The patterns from 13 of the 19 gastric biopsy specimens matched those of H. pylori isolates from the corresponding patients. The patterns from the remaining six biopsy specimens appeared to represent infection by two strains of H. pylori; the pattern of one strain was identical to that of the isolate from the corresponding patient. Combining the three restriction enzyme digestion patterns produced 19 distinct RFLP patterns for the 19 patients tested. The results suggest that the PCR-based RFLP analysis protocol described here may be useful as both a primary method and a typing scheme to directly identify and distinguish H. pylori strains from gastric biopsy specimens without culturing the organisms.
MATERIALS AND METHODS
Bacterial strains. The type strain, ATCC 43629, was used as a positive control in this study. Nineteen clinical H. pylori strains were isolated from the gastric biopsy specimens of 19 patients (19, 20 (8, 19, 26) .
Gastric biopsy specimens. Gastric biopsy specimens were obtained from patients who underwent endoscopy for upper gastrointestinal complaints at the Veterans Affairs Medical Center, Mountain Home, Tenn. Informed consent approved by the Institutional Review Board of East Tennessee State University was obtained in all instances. Three gastric biopsy specimens were collected from similar locations in the antrum of the stomach from each patient. One piece of each specimen was histologically examined by modified Steiner (silver) staining for the detection of H. pylori. A second piece was used to culture for H. pylori as described previously (8, 19) , and the remaining specimens were stored at Ϫ70°C for testing by PCR assay (20, 21) .
Preparation of genomic DNA for PCR assay. Genomic DNA from H. pylori isolates and non-H. pylori strains was prepared from freshly harvested bacterial cells that were grown on 6% sheep blood agar and incubated for 1 to 4 days at 37°C under the optimal atmospheric conditions for each isolate (8, 19, 26) . Genomic DNA from the frozen gastric biopsy specimens was prepared for PCR assay as described previously (20, 21) . Briefly, each frozen gastric biopsy specimen was suspended in 100 l of digestion buffer containing 10 g of proteinase K and incubated at 55°C for 3 h. The nucleic acids were extracted with an equal volume of phenol-chloroform and precipitated with absolute ethanol. The DNA pellets were washed with 75% ethanol and finally resuspended in 50 to 100 l of Tris-EDTA buffer. Human genomic DNA was prepared from leukocytes and used for specificity testing.
PCR amplification. The two 24-base oligonucleotides used as primers for the PCR assay were selected from published DNA sequences of the ureC gene in H. pylori, which encodes a required accessory protein for urease expression (16) . The primers were designated ureC-U (5Ј-CCC TCA CGC CAT CAG TCC CAA AAA-3Ј, from Ϫ383 to Ϫ360 bp) and ureC-L (5Ј-AAG AAG TCA AAA ACG CCC CAA AAC-3Ј, from 763 to 786 bp) and synthesized at the School of Hygiene and Public Health, Johns Hopkins University, with an Eppendorf Synostat-D DNA synthesizer and purified by reverse-phase high-pressure liquid chromatography (HPLC) method. As predicted, the amplification product with these two primers for DNAs prepared from the type strain of H. pylori, ATCC 43629, was 1,179 nucleotide pairs in length and represented a portion of the ureC gene starting Ϫ386 nucleotides upstream from the AGT start codon and ending 786 nucleotides downstream from the AGT start codon. Amplification was performed as described previously (20, 21) in 50-l reaction mixture volumes containing 0.5 M concentrations of each primer; 200 M (each) dATP, dCTP, dTTP, and dGTP; 1ϫ reaction buffer (50 mM KCl, 10 mM Tris-HCl [pH 8.3], 2.0 mM MgCl 2 , and 0.001% [wt/vol] gelatin); 1.25 U of Taq polymerase (Perkin-Elmer Cetus, Norwalk, Conn.); and 2 l of each DNA sample. Thirty cycles of amplification were performed in a DNA thermal cycler (GeneAmp 9600 system; Perkin-Elmer Cetus). Each cycle consisted of a 45-s denaturation step at 94°C, a 30-s annealing step at 59°C, and a 90-s extension step at 72°C. The final cycle included an extension step (10 min at 72°C) to ensure full extension of the product. A DNA preparation from the type strain was used as the positive control in each batch of PCR assays. For each batch of amplifications, a negative control tube containing distilled water in place of the DNA samples was also used.
Analysis of the PCR-amplified products. For identification of the amplified products, 10 l of the PCR mixture was analyzed by electrophoresis on 1.5% agarose gels (SeaKem LE agarose; FMC Products, Rockland, Maine). The amplified fragments were then transferred from the agarose gel to a nylon membrane (Nytran; Schleicher & Schuell, Keene, N.H.) and hybridized with a [ 32 P]dCTP-labeled DNA probe which was amplified from a DNA preparation from the type strain, ATCC 43629, with the above-described primers. Southern blot hybridization was performed as described previously (19, 21) .
RFLP analysis. After amplification, the PCR products were precipitated with 2.5 volumes of ethanol (20) . The pellets were washed twice with 75% ethanol and dissolved in Tris-EDTA buffer. The amplified DNA was then digested with the restriction enzymes HhaI, MboI, and AluI in the appropriate buffered solution for 3 h at 37°C in the appropriate buffered solution recommended by the manufacturer (Promega). The digested DNA fragments were analyzed by electrophoresis on 3.5% agarose gels (MetaPhor agarose; FMC Products). The gels were examined by transillumination and photographed. The sizes of digested DNA fragments were estimated from migration distances of molecular weight standards.
RESULTS
Development of a specific PCR assay for H. pylori. The PCR assay successfully amplified a fragment of the expected 1,179 bp from a DNA preparation from the H. pylori type strain, ATCC 43629, with the ureC-U and ureC-L primers. When genomic DNAs prepared from the 19 H. pylori isolates and the corresponding gastric biopsy specimens, from which the H. pylori strains were isolated, were used as templates, the PCR assay yielded DNA fragments of the same molecular weights as those obtained with the DNA preparation from the H. pylori type strain, ATCC 43629 (Fig. 1) 12 closely related non-Helicobacter species, and 4 urease-positive species not closely related to H. pylori were used to test the specificity of the PCR assay. All 22 of these non-H. pylori DNA preparations failed to amplify a product at the annealing temperature of 59°C when tested by agarose gel electrophoresis and Southern blot hybridization.
The sensitivity of the PCR assay has been tested by serial dilution of genomic DNA from H. pylori isolates and from gastric biopsy specimens. The 1,179-bp fragments were amplified by the PCR assay from a minimum of 0.1 pg of DNA from H. pylori (Fig. 2 ) and 2 ng of genomic DNA from gastric biopsy specimens. Since we chose the gastric biopsy specimen with the lowest density of PCR product (Fig. 1, lane 12) for the sensitivity test, the PCR assay could detect H. pylori DNA from a smaller amount of genomic DNA prepared from gastric biopsy specimens if the specimens contained a higher number of organisms. RFLP analysis. In order to determine whether the PCRbased RFLP analysis method could differentiate H. pylori strains directly from gastric biopsy specimens without culture, the PCR assay was performed on genomic DNA preparations from the 19 H. pylori isolates and from their corresponding gastric biopsy specimens. The 1,179-bp fragments produced by PCR assay were further digested with three restriction enzymes, HhaI, MboI, and AluI, and analyzed by agarose gel electrophoresis. When the PCR products from the 19 H. pylori isolates were subjected to RFLP analysis, it showed that 11, 10, and 6 distinguishable digestion patterns were generated by HhaI, MboI, and AluI, respectively (Table 1) . Combining the restriction enzyme digestion patterns obtained with HhaI, MboI, and AluI, we observed 19 distinct RFLP patterns from the 19 H. pylori isolates tested (Table 2) . However, when the PCR products from the 19 gastric biopsy specimens were digested by the restriction enzymes HhaI, MboI, and AluI, we observed 13, 11, and 6 RFLP patterns, respectively. The patterns from 13 of the 19 gastric biopsy specimens matched those from the corresponding H. pylori isolates from each patient. The patterns from the remaining six biopsy specimens appeared to represent infections with two strains of H. pylori; the pattern of one of the strains was identical to that of the isolate from the corresponding patient. As shown in Table 2 , gastric biopsy specimens from patients 3, 6, 7, 10, and 17 were probably colonized by two strains of H. pylori. With these five gastric biopsy specimens, each of the three restriction enzymes produced a combination pattern different from that of the isolate. Each combination pattern contained a pattern matching that from its corresponding isolate and a second pattern, presumably from another coinfecting strain. This suggests that the PCR-based RFLP assay can identify two, and maybe more, coinfecting H. pylori strains directly from gastric biopsy specimens. With the gastric biopsy specimen from patient 19, HhaI and AluI generated combination RFLP patterns different from that of the isolate, while MboI generated a pattern identical to that of the corresponding isolate. For patient 2, AluI digestion produced a combination RFLP pattern from the isolate but not from the gastric biopsy specimen. HhaI and MboI, however, generated identical patterns from the biopsy specimen and the corresponding isolate. Representative results of restriction enzyme digestion of PCR-amplified products from H. pylori isolates and their corresponding gastric biopsy specimens from each patient are shown in Fig. 3 .
DISCUSSION
In the present study, we successfully developed a PCR-based RFLP assay for the differentiation of H. pylori strains directly from gastric biopsy specimens without culture. By using the newly developed PCR-based RFLP assay, we have observed that 13, 11, and 6 distinct patterns were generated by three restriction enzymes, HhaI, MboI, and AluI, respectively, from 19 gastric biopsy specimens. The RFLP patterns from 13 of the 19 gastric biopsy specimens were found to be identical to those of the H. pylori isolates from the corresponding patients. The combination RFLP patterns from the remaining six gastric biopsy specimens suggested that two strains of H. pylori had colonized the stomachs of these six patients, with one of the two biopsy specimen patterns always matching that from its corresponding isolate. This suggests that the PCR-based RFLP assay may be useful as a primary approach for the identification of specific H. pylori strains in gastric biopsy specimens without culture.
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plus ureB (11) , and ureC (12, 25), have been described. These results have demonstrated a great diversity of urease genes among H. pylori clinical isolates. Foxall et al. (11) found that 10 distinct patterns were produced from 22 clinical isolates when the restriction enzyme HaeIII digested the 2.4-kb PCR products amplified from the ureA and ureB genes. Lopez et al. (22) reported that the patterns generated by HaeIII digestion of PCR products from ureA-ureB were almost as discriminatory as HaeIII ribopatterns. The data suggested that each pair of primers from urease genes was highly specific but that the sensitivity of each PCR primer pair was significantly affected by using unpurified target DNA in the assay, with detection rates varying from 0% (ureA plus ureB) to 55% (ureA) to 87.5% (ureC). Romero-Lopez et al. concluded that the smaller nucleotide product of the ureC primer assay was less susceptible to inhibition by a compound(s), as yet unidentified, present in heated cell lysates and that the ureC primer assay thus was the best of the urease gene PCR assays for the detection of H. pylori in clinical specimens. However, the sequence diversity of the ureC gene may result in some H. pylori organisms remaining undetected (3). In the present study, a PCR assay employing two 24-bp primers derived from the ureC gene sequence (16) (12) have shown that digestion of an 820-bp PCR-amplified portion of the ureC gene in H. pylori by the restriction enzymes HhaI, MboI, and MseI resulted in 10, 10, and 11 different patterns, respectively. The 25 H. pylori clinical isolates, however, could be grouped by the 25 distinct RFLP patterns produced when the three digestion patterns were combined. In our study, we used three types of restriction enzyme analyses of the 1,179-bp PCR product amplified from a portion of the ureC gene of H. pylori. Although 11, 10, and 6 digestion patterns were generated by HhaI, MboI, and AluI, respectively, 19 distinct RFLP patterns were observed among the 19 H. pylori clinical isolates when a combination of the three RFLP patterns was employed ( Table 2 ). Our data further suggest that PCR-based RFLP analysis of a portion of the ureC gene of H. pylori is a reliable scheme for differentiating H. pylori isolates.
Although several PCR-based RFLP protocols have been developed for the differentiation of H. pylori strains, they tested only H. pylori isolates from gastric biopsy specimens. Culture of H. pylori is time-consuming and not very sensitive. Our PCR-based RFLP protocol provides a means for the direct detection and differentiation of H. pylori strains in gastric biopsy specimens without culture. The combination RFLP patterns generated from the gastric biopsy specimens by the three restriction enzymes suggest the presence of two infecting strains of H. pylori in the stomachs of six patients. It has been previously reported that two strains of H. pylori have been found in the stomachs of some patients (12, 28, 30) . The results presented here suggest that the protocol may be useful for epidemiologic studies of H. pylori infections and for monitoring patients before and after eradication therapy to determine whether recurrence of ulcers following H. pylori eradication therapy is due to recrudescence or reinfection.
